
1.20 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.53 Today|||52-Week Range 2.34 | +107.08% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $151.5M |
Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City California 94063 |
Laurent Fischer | President, Chief Executive Officer & Director |
Peter Soparkar | Chief Operating & Legal Officer |
Linda M. Rubinstein | Chief Financial & Accounting Officer |
Heikki Jouttijärvi | Senior VP & Head-Technical Operations |
Bill Tan | SVP & Head-Global Clinical Operations |